REDWOOD CITY, Calif., Jan. 21, 2025 (GLOBE NEWSWIRE) -- Bluejay Therapeutics, a clinical-stage biopharmaceutical company dedicated to developing potentially life-changing therapeutics for serious ...
Findings showed patients treated with brelovitug achieved 100% virologic response on all dosing arms. The Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to brelovitug ...
The test can be used to detect HDV infection, a particularly dangerous coinfection that can occur with hepatitis B virus.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results